Shadows over data sharing

March 5, 2013

In a paper about to be published in EPJ Data Science, Barbara Jasny, deputy editor for commentary at Science magazine in Washington, DC, USA, looks at the history of the debates surrounding data access during and after the human genome "war". In this context, she outlines current challenges in accessing information affecting research, particularly with regard to the social sciences, personalised medicine and sustainability.

The trouble is that most researchers do not currently share their data. This is due both to and research culture. Scientists withholding data put forward various . These include the prohibitive amount of work involved, the need to withhold data prior to publication to retain a competitive advantage, or constraints associated with the itself when received under confidentiality agreements.

The author focused particularly on data sharing during the human genome sequencing race. The competition to present the first complete sequence of a human genome was then perceived as a battle. It set free access advocates—within the public research initiative funded primarily by the NIH and the UK Wellcome Trust—at odds with proponents of proprietary information—namely the US company Celera, which intended to exploit the data commercially. However, the situation became increasingly complex.

Further battles intensified after the publication of the draft genome in 2000. Although the public research initiative made data available, there were conditions on publishing research results based on the data. The data thus only became truly free to use after some delay.

Jasny concludes that two forces are currently impacting the research community: first, the need to protect individual privacy regarding information; and second, the push towards open access to data, which is increasingly being mandated by public funding agencies.

Explore further: New report explains why physicians are reluctant to share patient data

More information: B.R. Jasny (2013), Realities of data sharing using the genome wars as case study - an historical perspective and commentary, EPJ Data Science, 2:1, DOI: 10.1140/epjds13

Related Stories

Recommended for you

New class of RNA tumor suppressors identified

November 23, 2015

A pair of RNA molecules originally thought to be no more than cellular housekeepers are deleted in over a quarter of common human cancers, according to researchers at the Stanford University School of Medicine. Breast cancer ...

Batten disease may benefit from gene therapy

November 11, 2015

In a study of dogs, scientists showed that a new way to deliver replacement genes may be effective at slowing the development of childhood Batten disease, a rare and fatal neurological disorder. The key may be to inject viruses ...

Molecular clocks control mutation rate in human cells

November 9, 2015

Every cell in the human body contains a copy of the human genome. Through the course of a lifetime all cells are thought to acquire mutations in their genomes. Some of the mutational processes generating these mutations do ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.